Meta-analysis found 22.6% past-year misuse rates and 18.2% diversion rates for prescription stimulants. A 2024 Swedish JAMA Psychiatry study found that as ADHD prescription rates increased, the association with reduced injuries and crime weakened over time — suggesting expanded prescribing reached populations who didn't benefit. Paradoxically, research also showed many diagnosed patients who would benefit aren't receiving treatment.